Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Karen Hoyt promised her grandkids she would win a gold medal in the World Transplant Games. She wasn’t going to let HCC stand in her way.
Help find the “missing millions” who don’t know they’re living with viral hepatitis.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
Researchers analyzed health data regarding modern hep C treatments specific to New South Wales.
European and U.S. guidelines recommend that all those with cirrhosis undergo biannual screening for liver cancer.
People living with HIV are also facing cancer as they age.
Even positive breaking news looks different to people who know the reality of a hard-to-treat cancer.
Four things you should know to be #HepAware.
Do you know your liver cancer risk?
The VA has cured HCV in nearly 100,000 veterans, which will dramatically reduce the development of advanced liver disease and liver cancer.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
People with HIV who have higher viral load and worse immune function appear to be at higher risk for hepatocellular carcinoma.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
A third of patients taking neoadjuvant Opdivo had complete responses in an early analysis.
Cabometyx is the third liver cancer drug approved in the past six months.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.